Amreen Dinani, MD, is an Assistant Professor in the Department of Medicine, Division of Liver Diseases. Dr. Dinani completed her undergraduate degree in Human Biology at University of Toronto in Toronto, Canada and received her Masters in Science and Doctorate of Medicine from the American University of the Caribbean, St. Maarten. She completed her Internal Medicine residency at New York Hospital Queens/ New York Presbyterian Queens in Flushing, New York. She received her Gastroenterology training from McMaster University, Hamilton, Ontario, Canada and Hepatology training at University of Toronto, Toronto, Canada.
Dr. Dinani is a member of many professional societies including American Association of the Study of Liver Diseases and European Assoication of the Study of Liver Diseases. She also serves on the NAFLD Sig. She serves on the advisory committee for American Liver Foundation and involed in the planning of NASH (Nonalcoholic steatohepatitis) Day.Â
Dr. Dinani has a clinical and research niche in nonalcoholic fatty liver disease (NAFLD). She is the principle investigator of several industry sponsored trials in fatty liver disease but in addition has investigator initiated studies. Her areas of focus are identifying populations at high-risk for NAFLD, developing sustainable lifestyle programs and a multidisciplinary approach to NAFLD treatment. She has developed a screening program to identifyi NAFLD in persons with type 2 diabetes in priamry care clinic and an algorithm for those that need to be referred and co-managed with specialty care. She's also shown the feasibility and sustainability of a one- year lifestyle program for management of NAFLD. She currently collaborates with colleagues throughout Mount Sinai Healthcare Network to provide clinical care for persons with liver disease including the departments of Primary Care, Diabetologists, Emergency Medicine and Pulmonology. Her work has been presented at regional, national and international meetings.Â